Anthropic's CEO sees AI shaking up biotech, for better (and worse)

Anthropic CEO Dario Amodei thinks AI is on the cusp of radically changing biotech, with pharma companies already jumping in despite the hype. He sees both huge upsides for drug discovery and the potential for new—and unsettling—biological research.